MFS is caused by mutations in the Fbn1 gene, leading to increased TGF-β signaling, reduced smooth muscle contractility, and impaired endothelial function, all of which contribute to the development of aortic aneurysms [1,8]. The gene discussed is TGFB1; the disease is aortic aneurysm.